Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 3/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | MMP8 | P22894 | 2/20 | 0.35 |
| ▸ | MMP13 | P45452 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809751 | 0.80 | S1PR1 (0.40) | MGLLELANES1PR1MAOAMAOB | |
| SCHEMBL6809750 | 0.80 | S1PR1 (0.40) | MGLLELANES1PR1MAOAMAOB | |
| SCHEMBL7616779 | 0.73 | S1PR1 (0.53) | S1PR1MAOAMAOBMMP2MMP13 | |
| SCHEMBL7615649 | 0.72 | HTR1A (0.48) | MGLLS1PR1GAALMNAHTT | |
| SCHEMBL4455865 | 0.72 | — | — | |
| Lithium Ion SCHEMBL7617560 | 0.72 | S1PR1 (0.52) | S1PR1MAOAMAOBMMP2MMP13 | |
| SCHEMBL11256573 | 0.71 | ELANE (0.40) | ELANEGAABACE1MMP2MMP9 | |
| SCHEMBL2185091 | 0.71 | — | — | |
| SCHEMBL16553562 | 0.71 | — | — | |
| SCHEMBL15698583 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7598422-B2 | Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof | WYETH (US) | 2009-10-06 | — | — | US | disclosed |
| US-20070249869-A1 | Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof | WYETH (US) | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249869-A1 | Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof | ADH1C, ADH1A, ACMSD | MGLL 2412/4885ELANE 3080/4885S1PR1 2930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.